- Shares of Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) surged more than 100% after the companyreported that the FDA granted emergency expanded access for INOpulse to treat coronavirus.
- Shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) gained 29.8% after the company’s ePlex SARS-CoV-2 test received FDA emergency use authorization.
- Shares of Slack Technologies, Inc. (NYSE:WORK) rose 5.8% after the company reported adding 7,000 new paid customers beginning February which is more than the company added in the past 2 quarters.
- Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) gained14.5% after the clinical stage biopharma company said it's working on potential preventative treatment for SARS-CoV-2.
GenMark Diagnostics, Inc. (GNMK): Free Stock Analysis Report
Bellerophon Therapeutics, Inc. (BLPH): Get Free Report
Sorrento Therapeutics, Inc. (SRNE): Free Stock Analysis Report
Slack Technologies, Inc. (WORK): Free Stock Analysis Report
Original post